Canadian Startup Xagenic Raises $1M to Fund Chip-Based Molecular Diagnostics Platform
October 19, 2010
Canadian Startup Xagenic Raises $1M to Fund Chip-Based Molecular Diagnostics Platform
The firm is creating a class of chip-based molecular diagnostics that rely on nanostructured microelectrodes to achieve "highly sensitive nucleic acid sensors that detect DNA and RNA with record-breaking speed."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Xagenic Raises $10M to Develop Biochip System for Infectious Disease Testing
January 31, 2012 / BioArray News - Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - Canadian Government Provides MDx Firm Xagenic with $977K
February 19, 2013 / GenomeWeb Daily News - Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News - After 'Pivotal' 2012, Affy Looks to CytoScan, Axiom Genotyping Products to Drive Future Growth
February 5, 2013 / BioArray News